La Jolla Pharmaceutical Co [LJPC]
$8.72 0.06 (0.68%)
Market Cap 240 Million
La Jolla Pharmaceutical Co is an American biopharmaceutical company. The company's main activity is the discovery, development, and commercialization of innovative therapies that improve patients' life-threatening conditions. The company's portfolio consists of an angiotensin II formulation, which regulates blood pressure; a formulation of hepcidin, an endogenous peptide hormone that regulates iron metabolism; and an antibiotic approved by the U.S. Food and Drug Administration.
EPS -1.17 P/E Ratio 0.00
Previous Earnings Mon, Mar 4, 2019
Pay Date --
|Symbol||Price||Day %||YTD %|
This list of trending stocks may change throughout the trading day.